Genetic variations within the OPA1 gene are not associated with neuromyelitis optica

Multiple Sclerosis Journal

Volumn 18, Issue 2, 2012, Pages 240-243

  Sitarz, Kamil S ^a   Yu Wai Man, Patrick ^a,b   Hudson, Gavin ^a   Jacob, Anu ^c   Boggild, Mike ^c   Horvath, Rita ^a   Chinnery, Patrick F ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

demyelination; Devic's disease; dominant optic atrophy; mitochondria; neuromyelitis optica; OPA1

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GENE; GENE MUTATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MYELITIS; MYELOOPTIC NEUROPATHY; NUCLEOTIDE SEQUENCE; OPTIC ATROPHY 1 GENE; OPTIC NEURITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SPASTIC PARAPLEGIA; VISUAL DISORDER;

EID: 84856758318     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511416838     Document Type: Article

References (10)

1. Wingerchuk DM, Lennon VA, Lucchinetti CF, et al. The spectrum of neuromyelitis optica. Lancet Neurol. 2007 ; 6: 805-815 (Pubitemid 47238676)
2. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489 (Pubitemid 43958540)
3. Compston A. Complexity and heterogeneity in demyelinating disease. Brain. 2007 ; 130: 1178-1180 (Pubitemid 47355961)
4. Jacob A, Das K, Boggild M. Estimating the incidence and prevalence of neuromyelitis optica in the UK: extrapolating data from Merseyside. J Neurol Neurosurg Psychiatry. 2009 ; 80: e1
5. Yu-Wai-Man P, Griffiths PG, Chinnery PF. Mitochondrial optic neuropathies-disease mechanisms and therapeutic strategies. Prog Retinal Eye Res. 2011 ; 30: 81-114
6. Yu-Wai-Man P, Griffiths PG, Gorman GS, et al. Multi-system neurological disease is common in patients with OPA1 mutations. Brain. 2010 ; 133: 771-786
7. Baker MR, Fisher KM, Whittaker RG, Griffiths PG, Yu-Wai-Man P, Chinnery PF. Subclinical multi-system neurological disease in "pure" OPA1 autosomal dominant optic atrophy. Neurology. 2011 ;:
8. Wingerchuk DM. Neuromyelitis optica: effect of gender. J Neurol Sci. 2009 ; 286: 18-23
9. Hudson G, Mowbray C, Elson JL, et al. Does mitochondrial DNA predispose to neuromyelitis optica (Devic's disease)?. Brain. 2008 ; 131: e93
10. Yu-Wai-Man P, Stewart JD, Hudson G, et al. OPA1 increases the risk of normal but not high tension glaucoma. J Med Genet. 2010 ; 47: 120-125